 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
MCC (SOUTH AFRICA) |
|
|
CANADA |
|
|
|
|
HOME PAGE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biostudies, December 2003 |
|
|
Bioavailability and Bioequivalence Guidelines |
|
|
|
|
|
|
|
|
|
|
Generic Substitution, December 2003 |
|
|
Drug Interactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For web site of MCC, South Africa click here |
|
|
|
|
|
For website of Canada, click here |
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TGA (AUSTRALIA) |
|
|
BRAZIL |
|
|
|
  |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guidelines for Bioequivalence studies |
|
|
Bioavailability/Bioequivalence Good Practices Manual |
|
|
|
|
|
|
|
|
|
|
INDIA |
|
|
Registation of Generic Products |
|
|
|
|
|
|
|
|
|
|
Guidelines for Bioavailability & Bioequivalence studies |
|
|
Minimum Criteria required For BA/BE studies |
|
|
|
|
|
|
|
|
|
|
JAPAN |
|
|
List of Documents Required |
|
|
|
|
|
|
|
|
|
|
Clinical Pharmacokinetic Studies In Man |
|
|
Check List for Brazil Site Audit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ICH GCP |
|
|
WHO |
|
|
|
|
|
|
|
|
|
Prequalification Project (You can find all you need to know about WHO inspection and approval procedure of Bioequivalence centers. Inspection reports are also available under WHO Public inspection reports) |
|
|
Quality, Safety, Efficacy & Miscellaneous Guidelines (QSEM) |
|
|
|
|
|
|
|
DECLARATION OF HELSINKI |
|
|
|
|
|
|
|
|
52nd WMA General Assembly, Edinburgh, Scotland, October 2000 |
|
|
|
|
|
|
|
|
|
For US FDA Guidelines, Click here |
|
|
[email protected] |
|
|
|
|
|
|
|
|